Drugs / Genera
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT04307524 Comparator | Mar 2020 → Mar 2021 | — | Zagazig University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Genera | “patient will receive for three months daily without interruption, no pill-free interval drug names is "Genera" BAYERhealthcare” NCT04307524 ↗ |